 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
||||||||||
|
  |
|
Due Diligence |  printer friendly version |
||||||||||||||||||||||
|
|
|
|
|
||||||||||||||||||||
|
SHI Capital has assisted in due diligence associated with licensing and product acquisition opportunities in several therapeutic areas including CNS, oncology, and metabolic diseases. Our primary competence is an ability to provide deep technical, scientific and medical perspectives on the assumptions behind anticipated or forecasted sales. In the context of a company acquisition, SHI Capital’s value is to provide an in-depth validation of the company’s forecasted product sales. |
SHI congratulates Baycrest on the establishment of the innovative Centre for Brain Fitness. SHI was pleased to support Baycrest in securing a $10 million contribution from
|
||||||||||||||||||||||
|
| Terms & Conditions |
Copyright © 2006 SHI Capital. All Rights Reserved. |
